Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

The global cell and gene therapy third-party logistics market size was valued at USD 1.81 billion in 2025 and is predicted to ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.

Cell and gene therapies (CGTs) represent the cutting edge of drug discovery. 1 These are amongst the most advanced medical treatments, specifically designed to correct the root genetic cause of an ...

Two early-stage clinical trials demonstrate the safety and potential effectiveness of stem cell therapies to treat Parkinson’s disease (PD), the second most common neurological disease worldwide. PD ...

Immatics has innovative TCR therapies, strong cash position, and expanding clinical pipeline targeting solid tumors. Read for ...

This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and ...

These factors prompted research into better and more permanent treatments for T1D. The most obvious solution: restore the natural repertoire of β cell islets. Although most recipients experienced ...